- Home
- MBIO
MBIO
Mustang Bio Inc.
as 11-22-2024 4:00pm EST
| Founded: | 2015 | Country: | United States |
| Employees: | N/A | City: | WORCESTER |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | $2.00 | AVG Volume (30 days): | 1.3M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.15 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.13 - $1.68 | Next Earning Date: | 11-08-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Mustang Bio Inc. News
MBIO Breaking Stock News: Dive into MBIO Ticker-Specific Updates for Smart Investing
GlobeNewswire
12 days ago
Mustang Bio Receives Positive Listing Determination from Nasdaq
Pharmaceutical Technology
16 days ago
Mustang Bio’s MB-108 receives FDA orphan drug status for glioma treatment
MT Newswires
16 days ago
Mustang Bio Gets FDA Orphan Drug Designation for MB-108 in Malignant Glioma Treatment
GlobeNewswire
17 days ago
Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-108 (HSV-1 oncolytic virus) to Treat Malignant Glioma
TipRanks
a month ago
Mustang Bio Secures $4M through Strategic Warrant Agreement
GlobeNewswire
a month ago
Mustang Bio Announces Exercise of Warrants for $4 Million Gross Proceeds
GlobeNewswire
5 months ago
Diamond Equity Research Releases Update Note on Enveric Biosciences Inc. (NASDAQ: ENVB)
GlobeNewswire
5 months ago
Mustang Bio Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Compare MBIO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MBIO Mustang Bio Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.